1887

Abstract

cDNA cassettes encoding the foot-and-mouth disease virus (FMDV) structural protein precursor (P1-2A) together with the 3C protease, which cleaves this molecule to 1AB, 1C and 1D, were constructed. These cassettes were introduced into vaccinia virus (VV) transfer vectors. Attempts to isolate recombinant VVs constitutively expressing these cassettes were unsuccessful. However, when the P1-2A-3C cassette was placed under the control of the bacteriophage T7 promoter, stable VV/FMDV recombinants were isolated. Co-infection with recombinant VV vTF7-3 (which expresses T7 RNA polymerase) led to the production of correctly processed FMDV capsid proteins. Analysis by sucrose gradient centrifugation showed that material which co-sedimented with natural empty capsid particles (70S) was formed. Electron microscopy revealed empty capsid-like particles with diameters of about 30 nm. Studies using monoclonal antibodies specific for conformational epitopes indicated that the antigenicity of the synthetic particles was similar to whole virions and natural empty capsid particles. Surprisingly, merely the modification of a single amino acid residue within the myristoylation consensus sequence at the N terminus of P1-2A allowed the isolation of a recombinant VV which constitutively expressed the correctly processed proteins. However, the capsid proteins expressed from this mutant cassette failed to assemble into 70S empty particles.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-76-12-3089
1995-12-01
2022-05-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/76/12/JV0760123089.html?itemId=/content/journal/jgv/10.1099/0022-1317-76-12-3089&mimeType=html&fmt=ahah

References

  1. Acharya R., Fry E., Stuart D. I., Fox G., Rowlands D., Brown F. 1989; The three-dimensional structure of foot and mouth disease virus at 2.9 Å. Nature 337:709–716
    [Google Scholar]
  2. Ansardi D. C., Porter D. C., Morrow C. D. 1991; Co-infection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures. Journal of Virology 65:2088–2092
    [Google Scholar]
  3. Ansardi D. C., Porter D. C., Morrow C. D. 1992; Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles. Journal of Virology 66:4556–4563
    [Google Scholar]
  4. Belsham G. J. 1993; Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure. Progress in Biophysics and Molecular Biology 60:241–261
    [Google Scholar]
  5. Belsham G. J., Brangwyn J. K. 1990; A region of the 5′ noncoding region of foot-and-mouth disease virus RNA directs efficient internal initiation of protein synthesis within cells; interaction with the role of the L protease in translational control. Journal of Virology 64:5389–5395
    [Google Scholar]
  6. Belsham G. J., Brangwyn J. K., Ryan M. D., Abrams C. C., King A. M. Q. 1990; Intracellular expression and processing of foot-and-mouth disease virus capsid precursors using vaccinia virus vectors: influence of the L protease. Virology 176:524–530
    [Google Scholar]
  7. Belsham G. J., Abrams C. C., King A. M. Q., Roosien J., Vlak J. M. 1991; Myristoylation of foot-and-mouth disease virus capsid protein precursors is independent of other viral proteins and occurs in both mammalian and insect cells. Journal of General Virology 72:747–751
    [Google Scholar]
  8. Chow M., Newman J. F. E., Filman D., Hogle J. M., Rowlands D., Brown F. 1987; Myristylation of picornavirus capsid protein VP4 and its structural significance. Nature 327:482–486
    [Google Scholar]
  9. Curry S., Abrams C. C., Fry E., Crowther J. C., Belsham G. J., Stuart D. I., King A. M. Q. 1995; Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids. Journal of Virology 69:430–438
    [Google Scholar]
  10. Devaney M. A., Vakharia V. N., Lloyd R. E., Ehrenfeld E., Grubman M. J. 1988; Leader protein of foot-and-mouth disease virus is required for the cleavage of the p220 component of the capsid binding protein complex. Journal of Virology 62:4407–4409
    [Google Scholar]
  11. Elroy-Stein O., Fuerst T. R., Moss B. 1989; Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5′ sequence improves the performance of the vaccinia/bacteriophage T7 hybrid expression system. Proceedings of the National Academy of Sciences, USA 86:6126–6130
    [Google Scholar]
  12. Fuerst T. R., Earl P. L., Moss B. 1986; Use of a hybrid vaccinia virus–T7 RNA polymerase system for expression of target genes. Molecular and Cellular Biology 7:2528–2544
    [Google Scholar]
  13. Grubman M. J., Morgan D. O., Kendall J., Baxt B. 1985; Capsid intermediates assembled in a foot-and-mouth disease virus genome RNA programmed cell free translation system and in infected cells. Journal of Virology 56:120–126
    [Google Scholar]
  14. Jewell J. E., Ball L. A., Rueckert R. 1990; Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A. Journal of Virology 64:1388–1393
    [Google Scholar]
  15. Krausslich H. G., Nicklin M. J., Toyoda H., Etchison D., Wimmer E. 1987; Poliovirus protease 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220. Journal of Virology 61:2711–2718
    [Google Scholar]
  16. Krausslich H.G., Holscher C., Reuer Q., Harber J., Wimmer D. 1990; Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity. Journal of Virology 64:2433–2436
    [Google Scholar]
  17. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
    [Google Scholar]
  18. Lewis S. A., Morgan D. O., Grubman M. J. 1991; Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of neutralising antibody in pigs. Journal of Virology 65:6572–6580
    [Google Scholar]
  19. Mackett M., Smith G. L., Moss B. 1984; General method for production and selection of vaccinia virus recombinants expressing foreign genes. Journal of Virology 49:857–864
    [Google Scholar]
  20. Marc D., Drugeon G., Haenni A.L., Girard M., van der Were S. 1989; Role of myristoylation of polivirus capsid protein VP4 as determined by site-directed mutagenesis of its N-terminal sequence. EMBO Journal 8:2661–2668
    [Google Scholar]
  21. Marc D., Masson G., Girard M., Van der Werf S. 1990; Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious particles. Journal of Virology 64:4099–1107
    [Google Scholar]
  22. Rowlands D. J., Sangar D. V., Brown F. 1975; A comparative chemical and serological study of the full and empty particles of foot- and-mouth disease virus. Journal of General Virology 26:227–238
    [Google Scholar]
  23. Rueckert R. R. 1990; Picornaviridae and their replication. In Virology 2nd edn, pp 507–548 Edited by Fields B. N., Knipe D. M. New York: Raven Press;
    [Google Scholar]
  24. Rweyemamu M. M., Terry G., Pay T. W. F. 1979; Stability and immunogenicity of empty particles of foot-and-mouth disease virus. Archives of Virology 59:69–79
    [Google Scholar]
  25. Ryan M. D., Belsham G. J., King A. M. Q. 1989; Specificity of enzyme substrate interactions in foot-and-mouth disease virus polyprotein processing. Virology 173:35–45
    [Google Scholar]
  26. Tesar M., Jia X.-Y., Summers D. F., Ehrenfeld E. 1993; Analysis of a potential myristoylation site in hepatitis A virus capsid protein VP4. Virology 194:616–626
    [Google Scholar]
  27. Thomas A. A. M., Woortmeyer R. J., Puijk W., Barteling S. J. 1988; Antigenic sites on foot-and-mouth disease virus type A10. Journal of Virology 62:2782–2789
    [Google Scholar]
  28. Towler D. A., Gordon J. I., Adams S. P., Glaser L. 1988; The biology and enzymology of eukaryotic acylation. Annual Review of Biochemistry 57:69–99
    [Google Scholar]
  29. Turner P. C., Young D. C., Flanegan J. B., Moyer R. W. 1989; Interference with vaccinia virus growth caused by insertion of the coding sequence for poliovirus protease 2A. Virology 173:509–521
    [Google Scholar]
  30. Venkitaraman A. R. 1989; Use of modified T7 DNA polymerase (Sequenase version 2.0™) for oligonucleotide site directed mutagenesis. Nucleic Acids Research 17:3314
    [Google Scholar]
  31. Winokur P. L., McLinden J. H., Stapleton J. T. 1991; The hepatitis A virus polyprotein expressed by a recombinant vaccinia virus undergoes proteolytic processing and assembly into virus like particles. Journal of Virology 65:5029–5036
    [Google Scholar]
  32. Zhu N. L., Li G. D., Wang Y. 1994; Physiochemical and immunological characterization of hepatitis A virus nucleocapsids expressed in a vaccinia/T7/EMCV system. Archives of Virology 135:443–449
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-76-12-3089
Loading
/content/journal/jgv/10.1099/0022-1317-76-12-3089
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error